Biosimilars Advisory Service: Acceptance of Biosimilars Across Physician Specialties | Biosimilars Advisory Service | US/EU | 2014

The fledgling biosimilars industry is full of uncertainties and nuances that differ by country, therapeutic specialty, and molecule. Securing a positive return on lengthy biosimilar development depends on various factors, but knowledge is the key to success. Gaining physician confidence is critical to securing a meaningful position in developed markets; therefore, understanding their concerns about biosimilar products should be an important part of development and marketing strategies. We conducted primary market research with 548 specialty physicians across the United States and Europe to understand their perspectives on biosimilars and their expectations for use. To understand how physician attitudes vary across therapeutic fields, we surveyed six different types of specialists and posed questions about key topics that will influence uptake. Through our market research, we uncovered the trends in physician perceptions about biosimilars over time and how physicians from different specialties and geographies vary with respect to their opinions on automatic substitution, indication extrapolation, drivers and barriers of uptake, clinical concerns and requirements, and competition from new innovative biologics.

This report is part of the Biosimilars Advisory Service. The Biosimilars Advisory Service provides insight and analysis that are vital to successful business planning in the rapidly evolving biosimilars space. In-depth market analysis is delivered through regular webinars that put major events into context as well as in the form of reports supported by primary market research with physicians and payers. Interactive forecasts allow assessment of market opportunities and strategically focused reports help shape biosimilars’ development and defense strategies. Rely on BioTrends Research Group to keep up-to-date on the biosimilars landscape and poised to maximize opportunities.